{
  "trial_id": "NCT02762084",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, number of basal cell carcinomas (BCCs) at baseline, history of BCCs treated within 24 months prior to screening, presence of untreated surgically eligible BCCs (SEBs) at baseline, history of odontogenic keratocysts, presence of palmar/plantar pits, presence of bilamellar calcification of the falx cerebri, presence of fused/bifid/splayed ribs, family history of basal cell nevus syndrome, presence of PTCH1 gene mutation, presence of macrocephaly, presence of congenital malformations, presence of skeletal abnormalities, presence of radiological abnormalities, presence of ovarian fibroma, presence of medulloblastoma, history of systemic disease, history of liver disease, history of hypersensitivity to study drug ingredients, use of topical or systemic therapies that might interfere with study medication, history of invasive cancer within the past 5 years, current or recent participation in an experimental drug study, use of birth control methods for participants and their partners.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Weight"
      ],
      "remaining_candidate_features": [
        "number of basal cell carcinomas (BCCs) at baseline",
        "history of BCCs treated within 24 months prior to screening",
        "presence of untreated surgically eligible BCCs (SEBs) at baseline",
        "history of odontogenic keratocysts",
        "presence of palmar/plantar pits",
        "presence of bilamellar calcification of the falx cerebri",
        "presence of fused/bifid/splayed ribs",
        "family history of basal cell nevus syndrome",
        "presence of PTCH1 gene mutation",
        "presence of macrocephaly",
        "presence of congenital malformations",
        "presence of skeletal abnormalities",
        "presence of radiological abnormalities",
        "presence of ovarian fibroma",
        "presence of medulloblastoma",
        "history of systemic disease",
        "history of liver disease",
        "history of hypersensitivity to study drug ingredients",
        "use of topical or systemic therapies that might interfere with study medication",
        "history of invasive cancer within the past 5 years",
        "current or recent participation in an experimental drug study",
        "use of birth control methods for participants and their partners."
      ]
    },
    "processed-gen-response": "Age, gender, number of basal cell carcinomas (BCCs) at baseline, history of BCCs treated within 24 months prior to screening, presence of untreated surgically eligible BCCs (SEBs) at baseline, history of odontogenic keratocysts, presence of palmar/plantar pits, presence of bilamellar calcification of the falx cerebri, presence of fused/bifid/splayed ribs, family history of basal cell nevus syndrome, presence of PTCH1 gene mutation, presence of macrocephaly, presence of congenital malformations, presence of skeletal abnormalities, presence of radiological abnormalities, presence of ovarian fibroma, presence of medulloblastoma, history of systemic disease, history of liver disease, history of hypersensitivity to study drug ingredients, use of topical or systemic therapies that might interfere with study medication, history of invasive cancer within the past 5 years, current or recent participation in an experimental drug study, use of birth control methods for participants and their partners."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Number of Basal Cell Carcinomas (BCCs) at Baseline, History of BCCs, Family History of Basal Cell Nevus Syndrome (BCNS), Presence of Major Criteria for BCNS, Presence of Minor Criteria for BCNS, Baseline Tumor Size, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Number of Basal Cell Carcinomas (BCCs) at Baseline",
        "History of BCCs",
        "Family History of Basal Cell Nevus Syndrome (BCNS)",
        "Presence of Major Criteria for BCNS",
        "Presence of Minor Criteria for BCNS",
        "Baseline Tumor Size"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Number of Basal Cell Carcinomas (BCCs) at Baseline, History of BCCs, Family History of Basal Cell Nevus Syndrome (BCNS), Presence of Major Criteria for BCNS, Presence of Minor Criteria for BCNS, Baseline Tumor Size"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Number of Basal Cell Carcinomas, History of Medulloblastoma, Family History of Basal Cell Nevus Syndrome, PTCH1 Gene Mutation Status, Presence of Odontogenic Keratocysts, Presence of Palmar and/or Plantar Pits, Presence of Bilamellar Calcification of the Falx Cerebri, Presence of Fused, Bifid, or Markedly Splayed Ribs, Presence of Macrocephaly, Presence of Congenital Malformations, Presence of Skeletal Abnormalities, Presence of Radiological Abnormalities, Presence of Ovarian Fibroma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Number of Basal Cell Carcinomas",
        "History of Medulloblastoma",
        "Family History of Basal Cell Nevus Syndrome",
        "PTCH1 Gene Mutation Status",
        "Presence of Odontogenic Keratocysts",
        "Presence of Palmar and/or Plantar Pits",
        "Presence of Bilamellar Calcification of the Falx Cerebri",
        "Presence of Fused",
        "Bifid",
        "or Markedly Splayed Ribs",
        "Presence of Macrocephaly",
        "Presence of Congenital Malformations",
        "Presence of Skeletal Abnormalities",
        "Presence of Radiological Abnormalities",
        "Presence of Ovarian Fibroma."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Number of Basal Cell Carcinomas, History of Medulloblastoma, Family History of Basal Cell Nevus Syndrome, PTCH1 Gene Mutation Status, Presence of Odontogenic Keratocysts, Presence of Palmar and/or Plantar Pits, Presence of Bilamellar Calcification of the Falx Cerebri, Presence of Fused, Bifid, or Markedly Splayed Ribs, Presence of Macrocephaly, Presence of Congenital Malformations, Presence of Skeletal Abnormalities, Presence of Radiological Abnormalities, Presence of Ovarian Fibroma."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, weight, height, body mass index (BMI), race, ethnicity, medical history (including history of BCCs, odontogenic keratocysts, palmar and/or plantar pits, bilamellar calcification of the falx cerebri, fused, bifid, or markedly splayed ribs, first degree relative with basal cell nevus syndrome, PTCH1 gene mutation), number of BCCs, location of BCCs, diameter of BCCs, presence of macrocephaly, congenital malformations, skeletal abnormalities, radiological abnormalities, ovarian fibroma, medulloblastoma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Weight",
          "weight"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "height",
        "body mass index (BMI)",
        "medical history (including history of BCCs, odontogenic keratocysts, palmar and/or plantar pits, bilamellar calcification of the falx cerebri, fused, bifid, or markedly splayed ribs, first degree relative with basal cell nevus syndrome, PTCH1 gene mutation)",
        "number of BCCs",
        "location of BCCs",
        "diameter of BCCs",
        "presence of macrocephaly",
        "congenital malformations",
        "skeletal abnormalities",
        "radiological abnormalities",
        "ovarian fibroma",
        "medulloblastoma"
      ]
    },
    "processed-gen-response": "age, sex, weight, height, body mass index (BMI), race, ethnicity, medical history (including history of BCCs, odontogenic keratocysts, palmar and/or plantar pits, bilamellar calcification of the falx cerebri, fused, bifid, or markedly splayed ribs, first degree relative with basal cell nevus syndrome, PTCH1 gene mutation), number of BCCs, location of BCCs, diameter of BCCs, presence of macrocephaly, congenital malformations, skeletal abnormalities, radiological abnormalities, ovarian fibroma, medulloblastoma."
  }
}